A survey of monitoring of weight and blood glucose in in-patients

Psychiatric Bulletin

Volumn 27, Issue 11, 2003, Pages 424-426

  Boilson, Marie ^a   Hamilton, Ross J ^b  

^a NHS TAYSIDE   (United Kingdom)

^b ROYAL CORNHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; GLUCOSE; NEUROLEPTIC AGENT; OLANZAPINE;

ACUTE PSYCHOSIS; ARTICLE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; DELUSIONAL DISORDER; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MEDICAL RECORD; PRESCRIPTION; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; STANDARDIZATION; TEACHING HOSPITAL; WEIGHT GAIN;

EID: 0242552058     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.27.11.424     Document Type: Article

References (10)

1. Allison, D.B., Mentore, J., Heo, M., et al. (1999) Antipsychotic-induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry, 156, 1686-1696.
2. Baptista, T. (1999) Body weight-gain induced by antipsychotic drugs: Mechanisms and management. Acta Psychiatrica Scandinavica, 100, 3-16.
3. Brown, S., Barraclough, B. & Inskip, H. (2000) Causes of excess mortality in schizophrenia. British Journal of Psychiatry, 177, 212-217.
4. Committee on Safety of Medicines (2002) Olanzapine (Zyprexa) and diabetes. Current Problems in Pharmacovigilance, 28 (April), 3.
5. Fakhoury, W. K. H., Wright, D. & Wallace, M. (2001) Clinicians should pay more attention to weight gain and cognitive impairments as adverse effects of antipsychotic medication. (Press release 10 July 2001). London: Royal College of Psychiatrists. http://www.rcpsych.ac.uk/press/preleases/pr/pr_209.htm
6. Haupt, D.W. & Newcomer, J.W. (2001) Hyperglycaemia and antipsychotic medications. Journal of Clinical Psychiatry, 62 (suppl. 27), 15-26.
7. Kurzthaler, I. & Fleischhacker, W.W. (2001) The clinical implications of weight gain in schizophrenia. Journal of Clinical Psychiatry, 62 (suppl. 7), 32-37.
8. Mir, S. Taylor, D. (2001) Atypical antipsychotic and hyperglycemia. International Clinical Psychopharmacology, 16, 63-74.
9. Wetterling, T. (2001) Bodyweight gain with atypical antipsychotics, a comparative review. Drug Safety, 24, 59-73.
10. World Health Organization (1992) The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10). Geneva: WHO.